There's Good Cause To Be Excited About Amicus Therapeutics Clinical Program

By: via Benzinga
Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) were trading higher by more than 12 percent Wednesday after the company released ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.